Metabolomics reveals biomarkers of opioid use disorder

Metabolomics reveals biomarkers of opioid use disorder

Abstract Opioid use disorder (OUD) is diagnosed using the qualitative criteria defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Diagnostic biomarkers for OUD do not currently exist. Our study focused on developing objective biological markers to differenti...

Full description

Bibliographic Details
Main Authors: Reza Ghanbari, Yuanyuan Li, Wimal Pathmasiri, Susan McRitchie, Arash Etemadi, Jonathan D. Pollock, Hossein Poustchi, Afarin Rahimi-Movaghar, Masoumeh Amin-Esmaeili, Gholamreza Roshandel, Amaneh Shayanrad, Behrouz Abaei, Reza Malekzadeh, Susan C. J. Sumner
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Translational Psychiatry
Online Access:https://doi.org/10.1038/s41398-021-01228-7

Internet

https://doi.org/10.1038/s41398-021-01228-7

Similar Items